IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 317 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $55,957,000 | -36.7% | 1,100 | -50.0% | 0.01% | -35.3% |
| Q1 2017 | $88,440,000 | -80.1% | 2,200 | -76.3% | 0.02% | -80.2% |
| Q4 2016 | $444,819,000 | +26.5% | 9,300 | -3.1% | 0.09% | +41.0% |
| Q3 2016 | $351,744,000 | +30.2% | 9,600 | -17.2% | 0.06% | +29.8% |
| Q2 2016 | $270,164,000 | -45.3% | 11,600 | -4.9% | 0.05% | -48.9% |
| Q1 2016 | $494,100,000 | -34.6% | 12,200 | 0.0% | 0.09% | -29.2% |
| Q4 2015 | $755,546,000 | – | 12,200 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |